Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer Dec 2, 2008 07:30AM

BASKING RIDGE, N.J., Dec. 2 /PRNewswire/ -- Regado Biosciences, Inc., announced today the appointment of Ellen McDonald to the newly created position of Senior Vice President of Business Operations and Chief Business Officer, effective immediately. Ms. McDonald brings to Regado nearly 20 years of experience in the biopharmaceutical industry, with expertise heading business development, operations, portfolio management and marketing. She will report to David J. Mazzo, Ph.D., the Company's President and Chief Executive Officer. Dr. Mazzo stated, "Ellen has made critical contributions to Regado as a senior consultant, and we are very pleased to announce she is joining the Company's ...


Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008 Dec 1, 2008 07:30AM

BASKING RIDGE, N.J., Dec. 1 /PRNewswire/ -- Regado Biosciences, Inc., announced today David J. Mazzo, Ph.D., President and Chief Executive Officer, will present at the 20th Annual Piper Jaffray Health Care Conference in New York, NY, on Tuesday, December ...


Learn about the World Investment Services Market Brief Nov 18, 2008 08:14AM

NEW YORK--(BUSINESS WIRE)-- Reportlinker.com announces that a new market research report related to the Financial services industry is available in its catalogue. World Investment Services Market Brief http://www.reportlinker.com/p097808/World-Investment-Services-Market-Brief.html The global outlook series on Investment Services provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird's eye view of the prevalent scenario in the global Investment Services industry. The report provides a rudimentary insight ...


Quarterly Data Confirms Hedge Funds Exited Stocks In A Big Way Nov 17, 2008 05:17PM

If you pay attention to the stock market then you've probably heard about the problems in hedge fund land. For the past few months each day is filled with headlines about how much one fund lost and how another is being closed completely, and still others are pulling money out of the market. On Friday, we got a small glimpse on how bad things are getting. Each quarter, hedge funds larger than $100 million must file a 13F disclosing their long market positions as of the end of the quarter. Usually this quarterly ritual is a great way to find new stock ideas, but this quarter the filings just confirm some of the things we've heard about the trouble in the industry.

Below is data from 11 top hedge funds about where they stacked at the end of the quarter. For the most part, the data is showing a significant ...


Form 13F-HR CAXTON ASSOCIATES LLC For: Sep 30 Nov 14, 2008 04:40PM

http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=5982045




Nov 11, 2008 07:30AM Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance
Nov 10, 2008 03:16PM October Hammers Several Hedge Funds
Oct 14, 2008 07:30AM Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
Oct 3, 2008 11:52AM Caxton Associates Raises Stake in Ferro (FOE) to 5.2%
Oct 3, 2008 11:29AM Form SC 13G FERRO CORP Filed by: CAXTON ASSOCIATES LLC
Jun 27, 2008 09:44AM Caxton Associates Accumulates 5.1% Stake in Tercica (TRCA)
Jun 19, 2008 04:37PM Caxton Associates Accumulates 5.5% Stake in Innophos Holdings (IPHS)
Apr 7, 2008 09:40AM Caxton Associates Discloses 5.8% Stake in BladeLogic (BLOG)
Mar 24, 2008 04:21PM Kovner's Caxton Associates Boosts Stake in Stewart Enterprises (STEI) to 6.6%
Mar 11, 2008 04:39PM Caxton Associates Discloses 6.1% Stake in CollaGenex (CGPI)
Mar 3, 2008 04:23PM Kovner's Caxton Associates Boosts Stake in Rural Cellular (RCCC) to 6.1%